Isolation and deisolation of patients admitted with presumptive pulmonary tuberculosis

References

1. ↵
   1. World Health Organization. Pharmacological Reports

   (2018) WHO global tuberculosis report 2018 (World Health Organization, Geneva).
2. ↵
   1. World Health Organization

   (2019) WHO Guidelines on tuberculosis infection prevention and control [Update 2019] (World Health Organization, Geneva) Available from: https://www.who.int/tb/publications/2019/guidelines-tuberculosis-infection-prevention-2019/en/.
3. ↵
   1. Jensen PA,
   2. Lambert LA,
   3. Iademarco MF,
   4. Ridzon R

   (2005) CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 54(RR-17):1–141.

   OpenUrlPubMed
4. ↵
   1. Abad C,
   2. Fearday A,
   3. Safdar N

   (2010) Adverse effects of isolation in hospitalised patients:A systematic review. J Hosp Infect 76:97–102.

   OpenUrlCrossRefPubMed
5. ↵
   1. Sepkowitz KA,
   2. Friedman CR,
   3. Hafner A,
   4. Kwok D,
   5. Manoach S,
   6. Floris M,
   7. et al.

   (1995) Tuberculosis among urban health care workers:A study using restriction fragment length polymorphism typing. Clin Infect Dis 21:1098–101.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Edlin BR,
   2. Tokars JI,
   3. Grieco MH,
   4. Crawford JT,
   5. Williams J,
   6. Sordillo EM,
   7. et al.

   (1992) An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 326:1514–1521.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Migliori GB,
   2. Zellweger JP,
   3. Abubakar I,
   4. Ibraim E,
   5. Caminero JA,
   6. De Vries G,
   7. et al.

   (2012) Eur Respir J 39:807–819.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Wilmer A,
   2. Bryce E,
   3. Mdcm JG,
   4. Wilmer A,
   5. Bryce E,
   6. The JG,
   7. et al.

   (2011) The role of the third acid-fast bacillus smear in tuberculosis screening for infection control purposes:A controversial topic revisited. Can J Infect Dis Med Microbiol 22:5–7.

   OpenUrl
9. ↵
   1. Ipuge YAI,
   2. Rieder HL,
   3. Enarson DA

   (1996) The yield of acid-fast bacilli from serial smears in routine microscopy laboratories in rural Tanzania. Trans R Soc Trop Med Hyg 90:258–261.

   OpenUrlCrossRefPubMed
10. ↵
    1. Rieder HL,
    2. Chiang CY,
    3. Rusen ID

    (2005) A method to determine the utility of the third diagnostic and the second follow-up sputum smear examinations to diagnose tuberculosis cases and failures. Int J Tuberc Lung Dis 9:384–391.

    OpenUrlPubMed
11. ↵
    1. Chaisson LH,
    2. Roemer M,
    3. Cantu D,
    4. Haller B,
    5. Millman AJ,
    6. Cattamanchi A,
    7. et al.

    (2014) Impact of GeneXpert MTB/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: A hypothetical trial. Clin Infect Dis 59:1353–1360.

    OpenUrlCrossRefPubMed
12. ↵
    1. Campos M,
    2. Quartin A,
    3. Mendes E,
    4. Abreu A,
    5. Gurevich S,
    6. Echarte L,
    7. et al.

    (2008) Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. Am J Respir Crit Care Med 178:300–3005.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Millman AJ,
    2. Dowdy DW,
    3. Miller CR,
    4. Brownell R,
    5. Metcalfe JZ,
    6. Cattamanchi A,
    7. et al.

    (2013) Rapid molecular testing for TB to guide respiratory isolation in the U.S.:A cost-benefit analysis. PLoS One 8:1–8.

    OpenUrlCrossRefPubMed
14. ↵
    1. Lippincott CK,
    2. Miller MB,
    3. Popowitch EB,
    4. Hanrahan CF,
    5. Van Rie A

    (2014) Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States. Clin Infect Dis 59:186–192.

    OpenUrlCrossRefPubMed
15. ↵
    1. Boehme CC,
    2. Nabeta P,
    3. Hillemann D,
    4. Nicol MP,
    5. Shenai S,
    6. Krapp F,
    7. et al.

    (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363:1005–1015.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Malbruny B,
    2. Le Marrec G,
    3. Courageux K,
    4. Leclercq R,
    5. Cattoir V

    (2011) Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples. Int J Tuberc Lung Dis 15:553–555.

    OpenUrlCrossRefPubMed
17. ↵
    1. Behr MA,
    2. Warren SA,
    3. Salamon H,
    4. Hopewell PC,
    5. Ponce De Leon A,
    6. Daley CL,
    7. et al.

    (1999) Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353:444–449.

    OpenUrlCrossRefPubMedWeb of Science
18. 1. Hernández-Garduño E,
    2. Cook V,
    3. Kunimoto D,
    4. Elwood RK,
    5. Black WA,
    6. FitzGerald JM

    (2004) Transmission of tuberculosis from smear negative patients:A molecular epidemiology study. Thorax 59:286–290.

    OpenUrlAbstract/FREE Full Text
19. ↵
    1. Xie YL,
    2. Cronin WA,
    3. Proschan M,
    4. Oatis R,
    5. Cohn S,
    6. Curry SR,
    7. et al.

    (2018) Transmission of Mycobacterium tuberculosis from Patients Who Are Nucleic Acid Amplification Test Negative. Clin Infect Dis 67:1653–1659.

    OpenUrl
20. ↵
    1. National Tuberculosis Controllers Association

    (April 29, 2019) Consensus statement on the use of Cepheid Xpert MTB / RIF ®assay in making decisions to discontinue airborne infection isolation in healthcare settings, Updated 2016 April, Available from: http://www.tbcontrollers.org/docs/resources/NTCA_APHL_GeneXpert_Consensus_Statement_Final.pdf.
21. ↵
    1. Chaisson LH,
    2. Duong D,
    3. Cattamanchi A,
    4. Roemer M,
    5. Handley MA,
    6. Schillinger D,
    7. et al.

    (2018) Association of Rapid Molecular Testing with Duration of Respiratory Isolation for Patients with Possible Tuberculosis in a US Hospital. JAMA Intern Med 178:1380–1388.

    OpenUrl